On the public citation graph

An anti-SARS-CoV-2 non-neutralizing antibody with Fc-effector function defines a new NTD epitope and delays neuroinvasion and death in K18-hACE2 mice

https://doi.org/10.1101/2021.09.08.459408

0 signed · 114 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamainternmed.2020.4616openalex-snapshot

Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China

inferredcites →https://doi.org/10.1002/pro.3235openalex-snapshot

UCSF ChimeraX: Meeting modern challenges in visualization and analysis

inferredcites →https://doi.org/10.1002/pro.3943openalex-snapshot

UCSF ChimeraX : Structure visualization for researchers, educators, and developers

inferredcites →https://doi.org/10.1016/j.cell.2014.08.023openalex-snapshot

Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity

inferredcites →https://doi.org/10.1016/j.cell.2015.04.016openalex-snapshot

Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect

inferredcites →https://doi.org/10.1016/j.cell.2020.02.052openalex-snapshot

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

inferredcites →https://doi.org/10.1016/j.cell.2020.02.058openalex-snapshot

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

inferredcites →https://doi.org/10.1016/j.cell.2020.04.031openalex-snapshot

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

inferredcites →https://doi.org/10.1016/j.cell.2020.05.025openalex-snapshot

Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells

inferredcites →https://doi.org/10.1016/j.cell.2020.09.037openalex-snapshot

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

inferredcites →https://doi.org/10.1016/j.cell.2020.10.052openalex-snapshot

Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality

inferredcites →https://doi.org/10.1016/j.cell.2021.02.026openalex-snapshot

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

inferredcites →https://doi.org/10.1016/j.cell.2021.03.028openalex-snapshot

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

inferredcites →https://doi.org/10.1016/j.cell.2021.03.029openalex-snapshot

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

inferredcites →https://doi.org/10.1016/j.cell.2021.05.032openalex-snapshot

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies

inferredcites →https://doi.org/10.1016/j.cell.2021.06.021openalex-snapshot

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

inferredcites →https://doi.org/10.1016/j.celrep.2021.108790openalex-snapshot

Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2

inferredcites →https://doi.org/10.1016/j.celrep.2021.109353openalex-snapshot

Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects

inferredcites →https://doi.org/10.1016/j.celrep.2021.110210openalex-snapshot

Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern

inferredcites →https://doi.org/10.1016/j.chom.2020.04.004openalex-snapshot

An Infectious cDNA Clone of SARS-CoV-2

inferredcites →https://doi.org/10.1016/j.chom.2020.11.001openalex-snapshot

Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles

inferredcites →https://doi.org/10.1016/j.chom.2021.03.005openalex-snapshot

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

inferredcites →https://doi.org/10.1016/j.chom.2021.06.001openalex-snapshot

A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses

inferredcites →https://doi.org/10.1016/j.immuni.2020.06.001openalex-snapshot

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation

inferredcites →https://doi.org/10.1016/j.immuni.2021.08.015openalex-snapshot

Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy

inferredcites →https://doi.org/10.1016/j.jmb.2007.05.022openalex-snapshot

Inference of Macromolecular Assemblies from Crystalline State

inferredcites →https://doi.org/10.1016/j.jsb.2006.06.010openalex-snapshot

Visualizing density maps with UCSF Chimera

inferredcites →https://doi.org/10.1016/j.jsb.2015.08.007openalex-snapshot

Alignment of cryo-EM movies of individual particles by optimization of image translations

inferredcites →https://doi.org/10.1016/j.xcrm.2020.100126openalex-snapshot

Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike

inferredcites →https://doi.org/10.1016/j.xcrm.2021.100290openalex-snapshot

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

inferredcites →https://doi.org/10.1016/s0140-6736(20)30183-5openalex-snapshot

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

inferredcites →https://doi.org/10.1016/s0140-6736(20)32661-1openalex-snapshot

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

inferredcites →https://doi.org/10.1016/s0140-6736(21)00628-0openalex-snapshot

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

inferredcites →https://doi.org/10.1016/s0960-894x(98)00139-5openalex-snapshot

Structure based design: Novel spirocyclic ethers as nonpeptidal P2-ligands for HIV protease inhibitors

inferredcites →https://doi.org/10.1021/acscentsci.0c01537openalex-snapshot

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

inferredcites →https://doi.org/10.1038/nmeth.2115openalex-snapshot

Prevention of overfitting in cryo-EM structure determination

inferredcites →https://doi.org/10.1038/nmeth.3541openalex-snapshot

EMRinger: side chain–directed model and map validation for 3D cryo-electron microscopy

inferredcites →https://doi.org/10.1038/nmeth.4169openalex-snapshot

cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination

inferredcites →https://doi.org/10.1038/s41422-021-00497-7openalex-snapshot

Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms

inferredcites →https://doi.org/10.1038/s41423-020-0426-7openalex-snapshot

Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor

inferredcites →https://doi.org/10.1038/s41467-020-16256-yopenalex-snapshot

A human monoclonal antibody blocking SARS-CoV-2 infection

inferredcites →https://doi.org/10.1038/s41467-020-19055-7openalex-snapshot

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

inferredcites →https://doi.org/10.1038/s41467-020-19231-9openalex-snapshot

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation

inferredcites →https://doi.org/10.1038/s41579-021-00573-0openalex-snapshot

SARS-CoV-2 variants, spike mutations and immune escape

inferredcites →https://doi.org/10.1038/s41586-020-2008-3openalex-snapshot

A new coronavirus associated with human respiratory disease in China

inferredcites →https://doi.org/10.1038/s41586-020-2180-5openalex-snapshot

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

inferredcites →https://doi.org/10.1038/s41586-020-2380-zopenalex-snapshot

Human neutralizing antibodies elicited by SARS-CoV-2 infection

inferredcites →https://doi.org/10.1038/s41586-020-2456-9openalex-snapshot

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

inferredcites →https://doi.org/10.1038/s41586-020-2571-7openalex-snapshot

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

inferredcites →https://doi.org/10.1038/s41591-020-0965-6openalex-snapshot

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

inferredcites →https://doi.org/10.1038/sj.bdj.2008.993openalex-snapshot

A single dose

inferredcites →https://doi.org/10.1056/nejmc2036242openalex-snapshot

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

inferredcites →https://doi.org/10.1056/nejmoa030781openalex-snapshot

A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

inferredcites →https://doi.org/10.1056/nejmoa1211721openalex-snapshot

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

inferredcites →https://doi.org/10.1056/nejmoa2001017openalex-snapshot

A Novel Coronavirus from Patients with Pneumonia in China, 2019

inferredcites →https://doi.org/10.1056/nejmoa2034577openalex-snapshot

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

inferredcites →https://doi.org/10.1056/nejmoa2035389openalex-snapshot

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

inferredcites →https://doi.org/10.1073/pnas.0508123103openalex-snapshot

Engineered antibody Fc variants with enhanced effector function

inferredcites →https://doi.org/10.1073/pnas.1203954109openalex-snapshot

Mouse model recapitulating human Fcγ receptor structural and functional diversity

inferredcites →https://doi.org/10.1073/pnas.2003138117openalex-snapshot

Cell entry mechanisms of SARS-CoV-2

inferredcites →https://doi.org/10.1080/22221751.2020.1729069openalex-snapshot

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

inferredcites →https://doi.org/10.1084/jem.20201993openalex-snapshot

Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo

inferredcites →https://doi.org/10.1093/cid/ciab555openalex-snapshot

Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination

inferredcites →https://doi.org/10.1093/infdis/jiaa659openalex-snapshot

Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients

inferredcites →https://doi.org/10.1093/med/9780197521625.003.0008openalex-snapshot

Efficacy and Safety

inferredcites →https://doi.org/10.1093/nar/30.2.e9openalex-snapshot

High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells

inferredcites →https://doi.org/10.1093/nar/gkw361openalex-snapshot

SAbPred: a structure-based antibody prediction server

inferredcites →https://doi.org/10.1101/2020.11.05.369264openalex-snapshot

The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN

inferredcites →https://doi.org/10.1101/2021.02.05.429759openalex-snapshot

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination

inferredcites →https://doi.org/10.1101/2021.03.07.21253098openalex-snapshot

The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD

inferredcites →https://doi.org/10.1101/2021.04.03.438258openalex-snapshot

Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies

inferredcites →https://doi.org/10.1101/2021.07.09.451812openalex-snapshot

Impact of temperature on the affinity of SARS-CoV-2 Spike for ACE2

inferredcites →https://doi.org/10.1107/s0907444904019158openalex-snapshot

Coot : model-building tools for molecular graphics

inferredcites →https://doi.org/10.1107/s0907444909042073openalex-snapshot

MolProbity : all-atom structure validation for macromolecular crystallography

inferredcites →https://doi.org/10.1107/s0907444910007493openalex-snapshot

Features and development of Coot

inferredcites →https://doi.org/10.1107/s2059798317007859openalex-snapshot

Recent developments in the CCP-EM software suite

inferredcites →https://doi.org/10.1107/s2059798319011471openalex-snapshot

Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix

inferredcites →https://doi.org/10.1126/sciadv.abj5629openalex-snapshot

Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality

inferredcites →https://doi.org/10.1126/science.abb2507openalex-snapshot

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

inferredcites →https://doi.org/10.1126/science.abb7269openalex-snapshot

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

inferredcites →https://doi.org/10.1126/science.abc2241openalex-snapshot

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

inferredcites →https://doi.org/10.1126/science.abc6952openalex-snapshot

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

inferredcites →https://doi.org/10.1126/science.abd0826openalex-snapshot

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

inferredcites →https://doi.org/10.1126/science.abe3354openalex-snapshot

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

inferredcites →https://doi.org/10.1126/science.abf4830openalex-snapshot

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

inferredcites →https://doi.org/10.1126/science.abf6950openalex-snapshot

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

inferredcites →https://doi.org/10.1126/science.abg5268openalex-snapshot

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes

inferredcites →https://doi.org/10.1128/jcm.02005-20openalex-snapshot

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients

inferredcites →https://doi.org/10.1128/mbio.00281-21openalex-snapshot

COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions

inferredcites →https://doi.org/10.1128/mbio.01244-21openalex-snapshot

Erratum for Adeniji et al., “COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions”

inferredcites →https://doi.org/10.1128/mbio.02590-20openalex-snapshot

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals

inferredcites →https://doi.org/10.1142/9789814293648_0006openalex-snapshot

SAFETY AND EFFICACY

inferredcites →https://doi.org/10.1158/1535-7163.mct-08-0201openalex-snapshot

Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells

inferredcites →https://doi.org/10.1371/journal.pmed.0030237openalex-snapshot

Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants

inferredcites →https://doi.org/10.15252/embj.2020106267openalex-snapshot

Syncytia formation by SARS‐CoV‐2‐infected cells

inferredcites →https://doi.org/10.15252/embj.2020107405openalex-snapshot

Erratum To: Syncytia formation by SARS‐CoV‐2‐infected cells

inferredcites →https://doi.org/10.15585/mmwr.mm6923e4openalex-snapshot

SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members — USS Theodore Roosevelt, April 2020

inferredcites →https://doi.org/10.15585/mmwr.mm695152e1openalex-snapshot

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020

inferredcites →https://doi.org/10.15585/mmwr.mm7009e4openalex-snapshot

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021

inferredcites →https://doi.org/10.21203/rs.3.rs-200342/v1openalex-snapshot

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination

inferredcites →https://doi.org/10.3389/fimmu.2019.01296openalex-snapshot

Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life

inferredcites →https://doi.org/10.3389/fimmu.2020.576622openalex-snapshot

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens

inferredcites →https://doi.org/10.7554/elife.42166openalex-snapshot

New tools for automated high-resolution cryo-EM structure determination in RELION-3

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1016/j.celrep.2022.110336openalex-snapshot

SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people

inferred← citeshttps://doi.org/10.1016/j.celrep.2022.110757openalex-snapshot

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

inferred← citeshttps://doi.org/10.1016/j.chom.2021.12.004openalex-snapshot

Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses

inferred← citeshttps://doi.org/10.1038/s41467-022-32232-0openalex-snapshot

A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike

inferred← citeshttps://doi.org/10.1042/bst20210859openalex-snapshot

The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines

inferred← citeshttps://doi.org/10.1101/2021.12.01.470697openalex-snapshot

Macaque-human differences in SARS-CoV-2 Spike antibody response elicited by vaccination or infection

inferred← citeshttps://doi.org/10.1101/2023.03.09.531709openalex-snapshot

Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies

inferred← citeshttps://doi.org/10.1126/sciadv.abn4188openalex-snapshot

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities

inferred← citeshttps://doi.org/10.1172/jci.insight.170681openalex-snapshot

Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2

inferred← citeshttps://doi.org/10.3390/v14010005openalex-snapshot

SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells

inferred← citeshttps://doi.org/10.7554/elife.74489openalex-snapshot

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.